Observational retrospective evaluation of treatment with liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic cancer patients: An Italian large real-world analysis.

Antonio Pellino,Chiara Manai,Valeria Merz,Mario Scartozzi,Michele Milella,Ferdinando De Vita,Lorenzo Antonuzzo,Clizia Zichi,Maria Antonietta Satolli,Michele Panebianco,Silvia Noventa,Guido Giordano,Floriana Nappo,Camilla Zecchetto,Marco Puzzoni,Vanja Vaccaro,Annalisa Pappalardo,Elisa Giommoni,Davide Melisi,Sara Lonardi

Observational retrospective evaluation of treatment with liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic cancer patients: An Italian large real-world analysis.

2020

660Background: In the NAPOLI I phase III trial, Nanoliposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) showed better outcome compared to 5FU/LV in patients with metastatic Panc...

Keywords:

Fluorouracil
Metastatic pancreatic cancer
Internal medicine
Liposomal Irinotecan
Medicine
Observational study
Oncology
Pathology
in patient
Irinotecan

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations